Monday, June 27, 2016

Mayne Pharma nears deal for Teva assets -source

June 27 (Reuters) - Australian pharmaceutical company Mayne

Pharma Group Ltd is nearing a deal to purchase assets

from Teva Pharmaceuticals worth around $600 million, a

person familiar with the...

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)